Skip to main content

Table 1 Correlation expression of KIFC1 and clinicopathological parameters in 168 HCC cases in SYSUCC cohort

From: Correction to: KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity

Variable

All cases (N = 168)

KIFC1 expression (%)

P values

 

Low expression (N = 97)

High expression (N = 71)

Age (years)

   

0.763

 ≤ 51

90

51 (56.7)

39 (43.3)

 

 > 51

78

46 (59.0)

32 (41.0)

 

Sex

   

0.849

 Male

143

83 (58.0)

60 (42.0)

 

 Female

25

14 (56.0)

11 (44.0)

 

AFP (ng/ml)

   

0.652

 ≤ 20

72

43 (59.7)

29 (40.3)

 

 > 20

96

54 (56.3)

42 (43.7)

 

HBsAg

   

0.394

 negative

11

5 (45.5)

6 (54.5)

 

 positive

157

92 (58.6)

65 (41.4)

 

Cirrhosis

   

0.713

 No

99

56 (56.6)

43 (43.4)

 

 Yes

69

41 (59.4)

28 (40.6)

 

Necrosis

   

0.506

 No

76

46 (60.5)

30 (39.5)

 

 Yes

92

51 (55.4)

41 (44.6)

 

Clinical stage

   

0.009

 I-II

111

72 (64.9)

39 (35.1)

 

 III-IV

57

25 (43.9)

32 (56.1)

 

Histologic grade (WHO)

   

0.113

 G1-G2

83

53 (63.9)

30 (36.1)

 

 G3-G4*

85

44 (51.8)

41 (48.2)

 

Tumor size (cm)

   

0.031

 ≤ 5

73

49 (67.1)

24 (32.9)

 

 > 5

95

48 (50.5)

47 (49.5)

 

Tumor multiplicity

   

0.688

 Unifocal

128

75 (58.6)

53 (41.4)

 

 Multifocal

40

22 (55.0)

18 (45.0)

 

Intravascular emboli

   

0.688

 No

100

59 (59.0)

41 (41.0)

 

 Yes

68

38 (55.9)

30 (44.1)

 

Recurrence

   

0.037

 No

125

78 (62.4)

47 (37.6)

 

 Yes

43

19 (44.2)

24 (55.8)

 
  1. *:including 3 cases sarcomatoid liver cancer